AMS Advanced Medical Services

AMS is a privately held, full-service contract research organization (CRO) with over two decades of experience guiding life science companies through clinical development and regulatory approval. Headquartered in Mannheim with offices in Munich, London, Vienna, and Pennsylvania, the company offers a 360-degree suite of services including clinical trial management, global regulatory strategy, data analytics, and medical science for market access. It has established long-term relationships with major pharmaceutical clients like Boehringer Ingelheim, Pfizer, and Gilead, leveraging its therapeutic expertise in oncology, rare diseases, neurology, and other areas to bring products to patients efficiently.

Integrated clinical research organization (CRO) service platform offering end-to-end clinical development, regulatory strategy, data analytics, pharmacovigilance, and market access services, with specialized expertise in European Health Technology Assessment (HTA) and early benefit assessment (AMNOG).

AMS competes in the fragmented global Contract Research Organization (CRO) market, facing competition from large multinational CROs (e.g., IQVIA, ICON, Parexel) and smaller regional or specialized service providers. Its key competitive differentiation is its deep, specialized expertise in the complex German and European regulatory and market access environment, particularly for early benefit assessments.